Cardiovascular and Metabolism Discovery Matrix Lead (80-100%)

at  Roche

Roche fosters diversity, equity and inclusion, representing the communities we serve. When dealing with healthcare on a global scale, diversity is an essential ingredient to success. We believe that inclusion is key to understanding people’s varied healthcare needs. Together, we embrace individuality and share a passion for exceptional care. Join Roche, where every voice matters.
The Position
A healthier future. It’s what drives us to innovate. To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come. Creating a world where we all have more time with the people we love.
That’s what makes us Roche.
In Roche’s Pharmaceutical Research and Early Development organization (pRED), we make transformative medicines for patients in order to tackle some of the world’s toughest unmet healthcare needs. At pRED, we are united by our mission to transform science into medicines. Together, we create a culture defined by curiosity, responsibility, and humility, where our talented people are empowered and inspired to bring forward extraordinary life-changing innovation at speed.
The Position
pRED Cardiovascular & Metabolism, Immunology, Infectious Diseases and Ophthalmology (CMI2O), located in Basel, Switzerland, focuses on the discovery and early development of innovative treatments for specific diseases that affect the lives of millions. In the cardiovascular and metabolism area, we are developing cutting-edge therapies to treat metabolic diseases. As a member of the metabolism group, you will be part of an international group that includes scientists and clinicians who are developing medicines for the future.
We are currently looking for a science operation-oriented professional with a strong background in metabolism, a proven track record in managing target identification and validation in a drug discovery setting, strong leadership skills, and the proven ability to effectively lead projects in a matrix organization. You will be responsible for aligning a team of scientists and research associates that brings new targets into the portfolio and advances them to clinics.

Key responsibilities

• Act as an operational champion providing key guidance and oversight in the deployment and execution of the CVM discovery strategy
• Serve as a key operational member of the CVM discovery team working closely by interacting with senior leaders and key stakeholders across the pRED discovery technology ecosystem along with scientific experts from the CVM therapeutic area and functions
• Work collaboratively to continually evolve the CVM discovery strategy by innovating new approaches, staying up to date with the scientific literature, actively engaging with internal and external communities, and continuously evaluating new technologies and biology in the CVM space

Who you are

• A PhD degree in biology, chemistry, or a related field with minimally 5 years of professional experience in the pharmaceutical industry or biotech sector.
• Established a track record of scientific accomplishments and successful collaborations in the CVM space
• Proven track record of engagement with senior leaders and key stakeholders and leading cross-functional teams
• Strong awareness of the emerging trends and technology developments across the drug discovery arena

In addition to your operative skills, we are looking for an individual with a growth mindset and a proven track record in interacting in a matrix set-up with Senior Leaders.
You like to think outside the box and have demonstrated the ability to implement new ideas in a fast-paced research environment.
Your excellent understanding of the operations processes in early drug discovery & development, combined with your capability to act as a coach and mentor teams, are required to be successful in this role.
Your Location
This position is based in Basel.
Our commitment
Roche commits to recognizing talent and aptitude. We prioritize encouraging and supporting our employees on their personal journeys by providing a safe, creative space to help them reflect, make decisions and grow in their career.
We are confident that we find the most innovative solutions by gaining different perspectives, asking and answering hard questions, and challenging the status quo. Roche embraces diversity and equal opportunity in a serious yet enthusiastic way; we are devoted to building a team that represents a range of backgrounds, perspectives, and skills. The more inclusive we are, the better our work will be.
Who we are
At Roche, more than 100,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity.
Basel is the headquarters of the Roche Group and one of its most important centres of pharmaceutical research. Over 10,700 employees from over 100 countries come together at our Basel/Kaiseraugst site, which is one of Roche`s largest sites. Read more.
Besides extensive development and training opportunities, we offer flexible working options, 18 weeks of maternity leave and 10 weeks of gender independent partnership leave. Our employees also benefit from multiple services on site such as child-care facilities, medical services, restaurants and cafeterias, as well as various employee events.
We believe in the power of diversity and inclusion, and strive to identify and create opportunities that enable all people to bring their unique selves to Roche.

• Act as an operational champion providing key guidance and oversight in the deployment and execution of the CVM discovery strategy
• Serve as a key operational member of the CVM discovery team working closely by interacting with senior leaders and key stakeholders across the pRED discovery technology ecosystem along with scientific experts from the CVM therapeutic area and functions
• Work collaboratively to continually evolve the CVM discovery strategy by innovating new approaches, staying up to date with the scientific literature, actively engaging with internal and external communities, and continuously evaluating new technologies and biology in the CVM spac